From: Practices and challenges for hemophilia management under resource constraints in Thailand
Type of CFC | No. of products available | Dose/vial | Average price per IUa (THB; ± SD) | Average price per IUa (USD; ± SD) |
---|---|---|---|---|
Recombinant SHL FVIII concentrate | 3 | 250 IU 500 IU | 9.459 ± 1.744 | 0.270 ± 0.050 |
Plasma-derived SHL FVIII concentrate | 4 | 250 IU 500 IU | 9.030 ± 1.689 | 0.258 ± 0.048 |
Recombinant EHL FVIII concentrate | 2 | 500 IU | 9.785 ± 0.049 | 0.280 ± 0.001 |
Recombinant SHL FIX concentrate | 1 | 250 IU 500 IU | 10.216 ± 0.543 | 0.292 ± 0.016 |
Plasma-derived SHL FIX concentrate | 2 | 500 IU 600 IU | 10.656 ± 0.410 | 0.304 ± 0.012 |